Q'Apel Website Imagery - World

Where did our name come from?

We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.

Who We Are
View All Resources

Balloon guide catheter improves revascularization and clinical outcomes with the solitaire device analysis of the North American Solitaire Acute Stroke Registry.

October 15, 2013

Abstract, via the American Heart Association Journal:

Efficient and timely recanalization is an important goal in acute stroke endovascular therapy.

Several studies demonstrated improved recanalization and clinical outcomes with the stent retriever devices compared with the Merci device. The goal of this study was to evaluate the role of the balloon guide catheter (BGC) and recanalization success in a substudy of the North American Solitaire Acute Stroke (NASA) registry.\

Publication Link:
https://www.ahajournals.org/

Related readings.

Our utmost commitment: creating what works based specifically and urgently on what’s needed. Explore additional resources, publications, and webinars to learn more.

May 20, 2021

Q’Apel Medical Welcomes Jodie Fam, Vice President and General Manager, International

February 11, 2021

Q’Apel Medical Raises $22 Million to Grow Highly Innovative Neurovascular Access Platform & Scott Huennekens joins Board of Directors

May 21, 2020

Walrus early experience webinar.

May 21, 2020

The early experience, techniques, and best practices used at State University of NY at Stony Brook with Walrus Balloon Guide Catheter.